Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2006 | 1 |
2007 | 1 |
2008 | 2 |
2009 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
The role of Raf kinase inhibitor protein (RKIP) in health and disease.
Biochem Pharmacol. 2004 Sep 15;68(6):1049-53. doi: 10.1016/j.bcp.2004.04.024.
Biochem Pharmacol. 2004.
PMID: 15313400
Review.
Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.
Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC.
Beach S, et al.
Oncogene. 2008 Apr 3;27(15):2243-8. doi: 10.1038/sj.onc.1210860. Epub 2007 Oct 22.
Oncogene. 2008.
PMID: 17952120
Free PMC article.
Item in Clipboard
Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer.
Keller ET.
Keller ET.
For Immunopathol Dis Therap. 2011;2(1):89-94. doi: 10.1615/ForumImmunDisTher.v2.i1.
For Immunopathol Dis Therap. 2011.
PMID: 21984962
Free PMC article.
Item in Clipboard
Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.
Woods Ignatoski KM, Grewal NK, Markwart SM, Vellaichamy A, Chinnaiyan AM, Yeung K, Ray ME, Keller ET.
Woods Ignatoski KM, et al.
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):153-60. doi: 10.1016/j.ijrobp.2008.04.072.
Int J Radiat Oncol Biol Phys. 2008.
PMID: 18722266
Free PMC article.
Item in Clipboard
Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET.
Fu Z, et al.
Prostate. 2006 Feb 15;66(3):248-56. doi: 10.1002/pros.20319.
Prostate. 2006.
PMID: 16175585
Free article.
Item in Clipboard
EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.
DeHaan AM, Wolters NM, Keller ET, Ignatoski KM.
DeHaan AM, et al.
Prostate. 2009 Apr 1;69(5):528-37. doi: 10.1002/pros.20903.
Prostate. 2009.
PMID: 19143022
Free PMC article.
Item in Clipboard
Cite
Cite